• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

david ricks

  1. Lilly separates Elanco business; stock hits new yearly high

    Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...
    • anonymous
    • Thread
    • biotech david ricks donald trump drug price elanco animal health eli lilly merck novartis pfizer pharma
    • Replies: 20
    • Forum: Eli Lilly
Top Bottom
Back